Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Despite the slowdown in dealmaking, French drugmaker Sanofi on Monday agreed to buy immunology-focused biotech Blueprint Medicines in a deal worth up to $9.5bn and Bristol Myers Squibb struck an up to ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

The results of the vote on the election of the Board are as follows: ...

FDA says a ‘statistically significant’ benefit on overall survival is required to approve the ivonescimab antibody.

Fortress Biotech, Inc. has announced the acquisition of its subsidiary Checkpoint Therapeutics, Inc. by Sun Pharmaceutical Industries Limited, which closed on May 30, 2025, after receiving ...

Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up ...

Charlottesville biotech support helps startups like Luminoah and Rivus grow, with the Manning Institute and CvilleBioHub leading the way ...

ORIC's Phase 1b trial of ORIC-944 in mCRPC shows PSA responses and strong tolerability, with Phase 3 trials and financing ...